Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cancer cachexia.
Fearon KC, Moses AG. Fearon KC, et al. Among authors: moses ag. Int J Cardiol. 2002 Sep;85(1):73-81. doi: 10.1016/s0167-5273(02)00235-8. Int J Cardiol. 2002. PMID: 12163211 Review.
Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival.
Moses AG, Maingay J, Sangster K, Fearon KC, Ross JA. Moses AG, et al. Oncol Rep. 2009 Apr;21(4):1091-5. doi: 10.3892/or_00000328. Oncol Rep. 2009. PMID: 19288013
Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia.
DeJong CH, Busquets S, Moses AG, Schrauwen P, Ross JA, Argiles JM, Fearon KC. DeJong CH, et al. Among authors: moses ag. Oncol Rep. 2005 Jul;14(1):257-63. Oncol Rep. 2005. PMID: 15944798
Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer.
Skipworth RJ, Moses AG, Sangster K, Sturgeon CM, Voss AC, Fallon MT, Anderson RA, Ross JA, Fearon KC. Skipworth RJ, et al. Among authors: moses ag. Support Care Cancer. 2011 Mar;19(3):391-401. doi: 10.1007/s00520-010-0832-y. Epub 2010 Mar 12. Support Care Cancer. 2011. PMID: 20221887
Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients.
van Dijk DP, van de Poll MC, Moses AG, Preston T, Olde Damink SW, Rensen SS, Deutz NE, Soeters PB, Ross JA, Fearon KCh, Dejong CH. van Dijk DP, et al. Among authors: moses ag. J Cachexia Sarcopenia Muscle. 2015 Sep;6(3):212-21. doi: 10.1002/jcsm.12029. Epub 2015 Apr 20. J Cachexia Sarcopenia Muscle. 2015. PMID: 26401467 Free PMC article.
Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, Murray GD. Fearon KC, et al. Among authors: moses ag. J Clin Oncol. 2006 Jul 20;24(21):3401-7. doi: 10.1200/JCO.2005.04.5724. J Clin Oncol. 2006. PMID: 16849754 Clinical Trial.
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ. Fearon KC, et al. Among authors: moses ag. Gut. 2003 Oct;52(10):1479-86. doi: 10.1136/gut.52.10.1479. Gut. 2003. PMID: 12970142 Free PMC article. Clinical Trial.
Leptin and its relation to weight loss, ob gene expression and the acute-phase response in surgical patients.
Moses AG, Dowidar N, Holloway B, Waddell I, Fearon KC, Ross JA. Moses AG, et al. Br J Surg. 2001 Apr;88(4):588-93. doi: 10.1046/j.1365-2168.2001.01743.x. Br J Surg. 2001. PMID: 11298630
The cancer cachexia syndrome.
Fearon KC, Barber MD, Moses AG. Fearon KC, et al. Among authors: moses ag. Surg Oncol Clin N Am. 2001 Jan;10(1):109-26. Surg Oncol Clin N Am. 2001. PMID: 11406454 Review.
The anti-catabolic effects of n-3 fatty acids.
Ross JA, Moses AG, Fearon KC. Ross JA, et al. Among authors: moses ag. Curr Opin Clin Nutr Metab Care. 1999 May;2(3):219-26. doi: 10.1097/00075197-199905000-00005. Curr Opin Clin Nutr Metab Care. 1999. PMID: 10456251 Review.
Feedback